Review
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 14, 2014; 20(46): 17345-17351
Published online Dec 14, 2014. doi: 10.3748/wjg.v20.i46.17345
Table 2 Summary of previous reports on computed tomography perfusion and antiangiogenic therapy in colorectal cancer
Ref.YearNumber of patientsTime of CTP after the treatmentParameter changes
Willet et al[18]20046 (primary)After 12 d of administration of bevacizumabBF, BV/decrease
Willet et al[32]200932 (primary)After 12 d of administration of bevacizumabBF, PS/decrease
Anzidei et al[33]201118 (liver metastases)After 181 d of the treatment (including bevacizumab)BF, BV/slightly decrease (not significant)